CAS: 115043-27-1
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 2H-1,4-Benzothiazin-3(4H)-one, 4-methyl-2-(1-methylethyl)-2-[2-[4-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]-1-piperazinyl]butoxy]phenyl]-, hydrochloride (1:2), (2R)- REF: IN-DA000FRDCAS: 115043-27-1 | - - - | Prezzo su richiesta | Mer 13 Nov 24 |
 | HOE-166 HCl REF: TM-T71371CAS: 115043-27-1 | - - - | 1.660,00 €~2.826,00 € | Mer 15 Gen 25 |
2H-1,4-Benzothiazin-3(4H)-one, 4-methyl-2-(1-methylethyl)-2-[2-[4-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]-1-piperazinyl]butoxy]phenyl]-, hydrochloride (1:2), (2R)-
CAS:115043-27-1
Formula:
C37H51Cl2N3O5S
Peso molecolare:
720.7889 G/Mol
Ref: IN-DA000FRD
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Mercoledì 13 Novembre 2024
HOE-166 HCl
CAS:115043-27-1
HOE-166 HCl is a novel calcium receptor antagonist.
Formula:
C37H51Cl2N3O5S
Colore e forma:
Solid
Peso molecolare:
720.79
Ref: TM-T71371
| 25mg | 1.660,00 € | ||
| 50mg | 2.170,00 € | ||
| 100mg | 2.826,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 15 Gennaio 2025
